Ubiquitin-independent degradation of antiapoptotic MCL-1

Mol Cell Biol. 2010 Jun;30(12):3099-110. doi: 10.1128/MCB.01266-09. Epub 2010 Apr 12.

Abstract

Antiapoptotic myeloid cell leukemia 1 (MCL-1) is an essential modulator of survival during the development and maintenance of a variety of cell lineages. Its turnover, believed to be mediated by the ubiquitin-proteasome system, facilitates apoptosis induction in response to cellular stress. To investigate the contribution of ubiquitinylation in regulating murine MCL-1 turnover, we generated an MCL-1 mutant lacking the lysine residues required for ubiquitinylation (MCL-1(KR)). Here, we demonstrate that despite failing to be ubiquitinylated, the MCL-1(KR) protein is eliminated at a rate similar to that of wild-type MCL-1 under basal and stressed conditions. Moreover, the degradation of wild-type MCL-1 is not affected when ubiquitin-activating enzyme E1 activity is blocked. Likewise, both wild-type and MCL-1(KR) proteins are similarly degraded when expressed in primary lymphocytes. Supporting these findings, unmodified, in vitro-translated MCL-1 can be degraded in a cell-free system by the 20S proteasome. Taken together, these data demonstrate that MCL-1 degradation can occur independently of ubiquitinylation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Animals
  • Apoptosis* / drug effects
  • Cell Line
  • Cycloheximide / pharmacology
  • Embryo, Mammalian / cytology
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Half-Life
  • Hematopoietic System / cytology
  • Hematopoietic System / metabolism
  • Humans
  • Leupeptins / pharmacology
  • Mice
  • Mutant Proteins / metabolism
  • Mutation / genetics
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Proteasome Inhibitors
  • Protein Processing, Post-Translational* / drug effects
  • Protein Stability / drug effects
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Ubiquitin / metabolism*
  • Ubiquitin-Protein Ligases / metabolism
  • Ubiquitination / drug effects

Substances

  • Leupeptins
  • Mcl1 protein, mouse
  • Mutant Proteins
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Proteasome Inhibitors
  • Proto-Oncogene Proteins c-bcl-2
  • Ubiquitin
  • Cycloheximide
  • Ubiquitin-Protein Ligases
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde